An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy

PHASE4CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

March 22, 2021

Primary Completion Date

November 15, 2022

Study Completion Date

November 15, 2022

Conditions
Narcolepsy
Interventions
DRUG

JZP-258

Maximum nightly dosage of 9 grams, administered once, twice or thrice nightly, with no single dose \> 6 g

Trial Locations (28)

17822

Geisinger Clinic, Danville

20815

The Center for Sleep & Wake Disorders, Chevy Chase

28054

Clinical Research of Gastonia, Gastonia

29201

Bogan Sleep Consultants, LLC, Columbia

29425

Medical University of South Carolina, Department of Psychiatry and Behavioral Sciences, North Charleston

29732

Clinical Research of Rock Hill, Rock Hill

30281

Clinical Research Institute, Stockbridge

31210

Sleep Practitioners LLC, Macon

32789

Florida Pediatric Research Institute, LLC, Winter Park

33606

Clinical Research of West Florida, Inc, Tampa

34741

Pulmonary Disease Specialists, PA d/b/a PDS Research, Kissimmee

35007

Wright Clinical Research, LLC, Alabaster

35213

Sleep Disorders Center of Alabama, Birmingham

35254

Pulmonary Associates of the Southeast, PC, Birmingham

43017

Ohio Sleep Medicine Institute, Dublin

44195

Cleveland Clinic, Sleep Disorders Center, Cleveland

45245

Intrepid Research LLC, Cincinnati

49008

WMed Center for Clinical Research, Kalamazoo

55435

Minnesota Lung Center, Edina

63123

Clayton Sleep Institute, LLC, St Louis

78229

Sleep Therapy & Research Center, San Antonio

78731

FutureSearch Trials of Neurology, Austin

80918

Delta Waves, Inc., Colorado Springs

90025

Santa Monica Clinical Trials, Los Angeles

90048

Southern California Institute For Respiratory Diseases, Inc./ Tower Sleep Medicine, Los Angeles

Southern California Institute For Respiratory Diseases, Inc., Los Angeles

92705

SDS Clinical Trials, Inc, Santa Ana

94063

Stanford University- Sleep Medicine, Redwood City

Sponsors
All Listed Sponsors
lead

Jazz Pharmaceuticals

INDUSTRY